A novel DNA methylation-related gene signature for the prediction of overall survival and immune characteristics of ovarian cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A novel DNA methylation-related gene signature for the prediction of overall survival and immune characteristics of ovarian cancer patients ; volume:16 ; number:1 ; day:29 ; month:3 ; year:2023 ; pages:1-14 ; date:12.2023
Journal of ovarian research ; 16, Heft 1 (29.3.2023), 1-14, 12.2023
- Urheber
-
Wang, Sixue
Fu, Jie
Fang, Xiaoling
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-023-01142-0
- URN
-
urn:nbn:de:101:1-2023081421033050118481
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Sixue
- Fu, Jie
- Fang, Xiaoling
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma
A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer
A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer
Epigenetic signature predicts overall survival clear cell renal cell carcinoma
Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer
Developing a DNA Methylation Signature to Differentiate High-Grade Serous Ovarian Carcinomas from Benign Ovarian Tumors
MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas
A DNA methylation signature to improve survival prediction of gastric cancer
A novel methylation signature predicts extreme long-term survival in glioblastoma
A novel epigenetic signature for overall survival prediction in patients with breast cancer
A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma
Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma
A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer
A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer
Epigenetic signature predicts overall survival clear cell renal cell carcinoma
Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer
Developing a DNA Methylation Signature to Differentiate High-Grade Serous Ovarian Carcinomas from Benign Ovarian Tumors
MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas
A DNA methylation signature to improve survival prediction of gastric cancer
A novel methylation signature predicts extreme long-term survival in glioblastoma
A novel epigenetic signature for overall survival prediction in patients with breast cancer
A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma
Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma
A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer
A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer
Epigenetic signature predicts overall survival clear cell renal cell carcinoma
Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer
Developing a DNA Methylation Signature to Differentiate High-Grade Serous Ovarian Carcinomas from Benign Ovarian Tumors
MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas
A DNA methylation signature to improve survival prediction of gastric cancer
A novel methylation signature predicts extreme long-term survival in glioblastoma
A novel epigenetic signature for overall survival prediction in patients with breast cancer